Documents

	The Survival Guide for Clinical Trials is a complete guide of procedures for every Spanish Community and CIEC, which we have created to help you through the starting phase of any type of study You can request this guide for free by writing to: masinformacion@infociencia.com

	Infociencia contributes regularly to professional clinical investigation forums. We have recently participated in the Drug Information Association in Prague, with a presentation entitled "Mobile Devices: Making Data Entry Easier". Download the presentation in PDF format here.

	Presentation by Infociencia in the Platform of Innovative Medicines on Knowledge Discovery in Clinical Databases. Infociencia performs its own statistical research for the extraction of scientific knowledge from clinical databases, using advanced statistical techniques. Download the presentation in PDF format here.

	Article on Infociencia, published in the AVUI newspaper (Barcelona), October 6, 2007. Download article in PDF format here

	Article on the future of CROs published in the New England Journal of Medicine Download article in PDF format here

	Interview with Jordi Naval in the prestigious international journal CenterWatch. You can read the interview in PDF format here

Some articles recently published:

Grandas F, Hernández B; PRACTICOMT Study Group. Long-term effectiveness and quality of life improvement in entacapone-treated Parkinson's disease patients: the effects of an early therapeutic intervention. Eur J Neurol 2007;14:282-9.Read more
Márquez Contreras E, de la Figuera von Wichmann M, Roig Ponsa L, Naval Chamosa J. Compliance with hypertension therapy in Spain, according to the views of family doctors. Complex Project. Aten Primaria 2007;39:417-23.Read more
Martín-Baranera M, Campo C, Coca A, de la Figuera M, Marín R, Ruilope LM; en representación del Grupo de Investigadores DICOPRESS. Stratification and degree of control of cardiovascular risk factors in hypertensive Spanish population. Results of the DICOPRESS study Med Clin (Barc) 2007;129:247-51.Read more
Porta N, Bonet C, Cobo E. Discordance between reported intention-to-treat and per protocol analyses. J Clin Epidemiol 2007;60:663-9.Read more
Poveda Velasco A, Casado Herráez A, Cervantes Ruipérez A, Gallardo Rincón D, García García E, González Martín A, López García G, Mendiola Fernández C, Ojeda González B; GEICO Group. Treatment guidelines in ovarian cancer. Clin Transl Oncol 2007;9:308-16. Read more
Blanco Quirós A, Díaz Castella JM, Balañá Vilanova M, Valveny Llobet N. Risk factors for atopic dermatitis and familial prevalence in Spain (ELIHO study). An Pediatr (Barc) 2005;63:480-8. Read more
Márquez Contreras E, de la Figuera von Wichmann M, Gil Guillén V, Ylla-Catalá A, Figueras M, Balaña M, Naval J. Effectiveness of an intervention to provide information to patients with hypertension as short text messages and reminders sent to their mobile phone (HTA-Alert). Aten Primaria 2004;34:399-405. Read more
Salas-Puig J, Serratosa JM, Viteri C, Gil-Nágel-Rein A; Grupo Español del Estudio SKATE. Safety of levetiracetam as adjunctive therapy in epilepsy: the SKATE trial in Spain. Rev Neurol 2004;38:1117-22. Read more
Torregrosa JV, Fuster D, Ybarra J, Ortín J, Moreno A, Valveny N. Predicting the effect of intravenous calcitriol on parathyroid gland activity using double-phase technetium Tc 99m-sestamibi scintigraphy. Am J Kidney Dis 2004;44:476-80. Read more